TTAN
ServiceTitan, Inc.
$80.71
+3.13% 2026-10-20
Technology
TTANSPY
1W
+12.5%
1M
+46.6%
3M
+10.6%
6M
+25.9%
YTD
-24.2%
1Y
-13.7%
Live chart
Loading live chart…
Grades vs sector
MomentumNot enough data yet–
Momentum
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
GrowthNot enough data yet–
Growth
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ValueNot enough data yet–
Value
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ProfitabilityNot enough data yet–
Profitability
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsAspire Report Finds Commercial Landscapers Prioritizing Growth as Businesses Navigate Operational Complexity
GlobeNewswire · Oct 13
ServiceTitan Launches Property Care for Enterprise Pest Control, Lawn Care, and Pool & Spa Markets
GlobeNewswire · Oct 13
Strength Seen in CCC Intelligent Solutions (CCC): Can Its 8.1% Jump Turn into More Strength?
Zacks · Oct 13
Aspire To Unveil Command Center at Ignite 2026, Bringing AI-Powered Insights and Action Together for Landscape Contractors
GlobeNewswire · Oct 08
FieldRoutes To Unveil Next Phase of Product Innovation at Ignite 2026
GlobeNewswire · Oct 08
Key stats
Market cap$7.8B
P/E (trailing)–
P/E (forward)49.1
52-week range53.00 – 111.36
Revenue growth (YoY, latest qtr)+20.9%
Dividend yield0.00%
Analyst consensusStrong Buy (15)
Mean price target$97.53 (+21%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +1 (DCF counts double).
•DCF (base case)below the price by 8%
•Piotroski F-score6/9
▲Altman Z23.2 (safe)
▲Analyst target+21% (15 analysts)
Discounted cash flow
Bear
$39
-52%
growth 14% · disc. 10.2% · term. 2.0%
Base
$74
-8%
growth 24% · disc. 9.2% · term. 2.5%
Bull
$128
+59%
growth 30% · disc. 8.2% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 19% a year for 10 years.
Implied
+19%/yr
FCF, last 3 yrs
n/a
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
+27%/yr
Revenue, last 5 yrs
n/a
Same inputs as the DCF above: trailing free cash flow 0.1B, 9.2% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2026; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-07-31). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $1.64 vs trailing $-1.36. Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
RPO
$527.4M
as of 2026-07-31
vs a year ago
–
YoY
× TTM revenue
0.50×
coverage
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Gross margin
71.1%
Operating margin
-13.0%
FCF margin
12.8%
Net margin
-12.1%
Return on equity
-8.0%
Return on invested capital
-9.7%
Net debt / EBITDA
–
Current ratio
4.5×
Interest cover
-39.4×
Cash conversion (OCF/NI)
–
Piotroski F-score 6/9 · last two fiscal years
✗ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✓ Gross margin improved✓ Asset turnover improved
Altman Z-score 23.2 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$98
+21%
Analysts
15
Strong Buy
Range
$76–$110
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $961.0M | $-159.9M | $105.4M |
| 2025 | $771.9M | $-239.1M | $33.3M |
| 2024 | $614.3M | $-195.1M | $-68.1M |
| 2023 | $467.7M | $-269.5M | $-194.7M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +27.1%.
Earnings
Next report: 2026-12-03 · during market · EPS est 0.26
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-09-08 | 0.35 | 0.40 | +14.2% |
| 2026-06-04 | 0.28 | 0.37 | +34.2% |
| 2026-03-12 | 0.18 | 0.27 | +52.8% |
| 2025-12-04 | 0.15 | 0.24 | +56.0% |
| 2025-09-04 | 0.18 | 0.33 | +87.3% |
| 2025-06-05 | 0.12 | 0.18 | +46.2% |
| 2025-03-13 | 0.03 | 0.12 | +301.3% |
| 2025-01-13 | -0.03 | -0.03 | -11.4% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-07-31 | $292.8M | +20.9% |
| 2026-04-30 | $268.8M | – |
| 2026-01-31 | $254.0M | – |
| 2025-10-31 | $249.2M | – |
| 2025-07-31 | $242.1M | – |
Analyst actions
TD Cowen
PT $100
2026-10-07 · reit
Buy → BuyPT $100
BTIG
PT $110
2026-10-02 · reit
Buy → BuyPT $110
TD Cowen
PT $100
2026-09-25 · reit
Buy → BuyPT $100
Citigroup
PT $76
2026-09-09 · main
Neutral → NeutralPT $76
Canaccord Genuity
PT $90
2026-09-09 · main
Buy → BuyPT $90
Morgan Stanley
PT $92
2026-09-09 · main
Overweight → OverweightPT $92
Insider trades
Sherry David
$4.2K
Chief Financial Officer · 2026-10-15
SELL$4.2K
Sherry David
$4.5K
Chief Financial Officer · 2026-10-15
SELL$4.5K
Sherry David
$7.6K
Chief Financial Officer · 2026-10-15
SELL$7.6K
Sherry David
$33.1K
Chief Financial Officer · 2026-10-15
SELL$33.1K
Sherry David
$36.2K
Chief Financial Officer · 2026-10-15
SELL$36.2K
O'Connor Michele
$268.7K
Chief Accounting Officer · 2026-09-23
SELL$268.7K
Sherry David
$1.3M
Chief Financial Officer · 2026-09-17
SELL$1.3M
O'Connor Michele
$318.5K
Chief Accounting Officer · 2026-09-17
SELL$318.5K
Kuzoyan Vahe
$179.6K
Director, President · 2026-09-17
SELL$179.6K
Mahdessian Ara
$179.6K
Director, Chief Executive Officer · 2026-09-17
SELL$179.6K
Sherry David
$572.7K
Chief Financial Officer · 2026-08-14
SELL$572.7K
Sherry David
$240.6K
Chief Financial Officer · 2026-08-14
SELL$240.6K
Stats refreshed 2026-10-20 17:52:36 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteauCoteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.